Organogenesis Holdings (ORGO) Total Non-Current Liabilities (2017 - 2026)

Organogenesis Holdings' Total Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $137.2 million for Q1 2026.

• On a quarterly basis, Total Non-Current Liabilities rose 39.35% year-over-year to $137.2 million in Q1 2026; TTM through Mar 2026 was $137.2 million, a 39.35% increase from a year earlier, with the FY2025 full-year figure at $163.6 million, up 46.51% from the prior year.
• Total Non-Current Liabilities fell to $137.2 million in Q1 2026 per ORGO's latest filing, from $163.6 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $202.0 million in Q2 2022 and bottomed at $96.9 million in Q2 2025.
• The 5-year median for Total Non-Current Liabilities is $178.4 million (2024), against an average of $162.1 million.
• Biggest YoY gain for Total Non-Current Liabilities was 46.51% in 2025; the steepest drop was 45.69% in 2025.
• Year by year, Total Non-Current Liabilities stood at $182.6 million in 2022, then fell by 1.32% to $180.1 million in 2023, then plunged by 38.01% to $111.7 million in 2024, then surged by 46.51% to $163.6 million in 2025, then retreated by 16.17% to $137.2 million in 2026.
• Per Business Quant, the three latest ORGO Total Non-Current Liabilities figures stand at $137.2 million (Q1 2026), $163.6 million (Q4 2025), and $121.3 million (Q3 2025).